Tesetaxel Clinical Data in Gastric Cancer and Breast Cancer to be Featured at ASCO Annual Meeting

BERKELEY HEIGHTS, N.J., April 4, 2012 (GLOBE NEWSWIRE) -- Genta Incorporated (OTCBB:GNTA) announced today that its lead compound, tesetaxel, will be featured in multiple presentations of new clinical data at the upcoming Annual Meeting of the American Society of Clinical Oncology (ASCO). The meeting will be held June 1-5, 2012, in Chicago, IL. At the meeting, results from a confirmatory Phase 2 trial of tesetaxel, the leading oral taxane in clinical development, will be reported for overall respons...continued GNTA  pharmaceutical biotechnology clinical

URL: http://www.investorpoint.com/news/OTCBULLB/50030784/